Don’t Use Antibiotics At Surgical Site For Beyond 48 Hours: ICMR Advisory

NEW DELHI : Antibiotics to prevent infection at the surgical site should not continue beyond 48 hours, the Indian Council of Medical Research (ICMR) has said.

As per the agency, prolonged antibiotic administration to prevent infection or prophylaxis is not only ineffective in reducing infections but increases antimicrobial resistance and the risk of infection with Clostridium Difficile – inflammation of the colon.

“Most studies have demonstrated efficacy of perioperative antibiotic prophylaxis for only 12 hours or less. Whenever short and long courses are compared, the shorter course has proven equally effective. A single dose is as effective as multiple doses, and antimicrobial prophylaxis after wound closure is unnecessary,” it adds.

The ICMR advisory comes in the wake of an increased antimicrobial resistance, especially in hospital settings. Many doctors continue antibiotic therapy for a week to 10 days only to prevent infection post-surgery which, the ICMR says, should be discouraged.

Another common practice followed by doctors is the use of broad-spectrum antibiotics – antibiotics that act on the two major bacterial groups, Gram-positive and Gram-negative – instead of narrow-spectrum antibiotics that target a select group only. The ICMR, in its latest guideline says, antibiotics should be chosen on the basis of their effectiveness against the pathogens most likely to be encountered rather than against every possible pathogen.

  • Related Posts

    Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

    Mumbai: A promoter entity of Ajanta Pharma Ltd. on Tuesday offloaded a nearly 3% stake in the company through open market transactions, even as domestic institutional investors stepped in to absorb a large…

    FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

    Pune: In a major crackdown against illegal pharmaceutical activities that compromise public health, the Food and Drug Administration (FDA) has seized a stock of medicines worth above Rs24.81 lakh from…

    Leave a Reply

    Your email address will not be published. Required fields are marked *

    You Missed

    Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

    Ajanta Pharma Promoter Sell 3% Stake Worth ₹1,024 Crore; Shares Trade Higher

    FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

    FDA cracks down on illegal drug trade, stock worth about ₹25 lakh seized from Pune and Kolhapur

    ICMR-NIN study links micronutrient deficiencies to higher dementia risk

    ICMR-NIN study links micronutrient deficiencies to higher dementia risk

    Pvt nursing home sealed in Chatra after woman, unborn baby die

    Pvt nursing home sealed in Chatra after woman, unborn baby die

    30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

    30 docs from 9 states guilty of taking pharma company junket, no action yet by 6 state medical councils

    Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy

    Scheme to build bulk drugs’ R&D, capacity in works, says Pharma secy